Susquehanna International Group
UBX

Susquehanna International Group’s Unity Biotechnology UBX Stock Holding History

Susquehanna International Group’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,200
Closed -$22K – 13748
2025
Q1 		$22K Buy
+21,200
New +$38.3K ﹤0.01% 12089
2023
Q3 		– Sell
-17,300
Closed -$44.1K – 13024
2023
Q2 		$44.1K Buy
17,300
+5,700
+49% +$15.1K ﹤0.01% 11384
2023
Q1 		$18.9K Sell
11,600
-5,900
-34% -$23.6K ﹤0.01% 12068
2022
Q4 		$48K Buy
17,500
+16,030
+1,090% +$46.6K ﹤0.01% 11425
2022
Q3 		$6K Sell
1,470
-670
-31% -$4.23K ﹤0.01% 12862
2022
Q2 		$12K Buy
2,140
+30
+1% +$250 ﹤0.01% 12480
2022
Q1 		$24K Sell
2,110
-5,510
-72% -$61.8K ﹤0.01% 12575
2021
Q4 		$111K Buy
7,620
+6,270
+464% +$137K ﹤0.01% 12069
2021
Q3 		$41K Sell
1,350
-1,610
-54% -$56.8K ﹤0.01% 12412
2021
Q2 		$137K Sell
2,960
-590
-17% -$28.4K ﹤0.01% 11906
2021
Q1 		$213K Buy
3,550
+960
+37% +$65.5K ﹤0.01% 11317
2020
Q4 		$136K Sell
2,590
-600
-19% -$28.9K ﹤0.01% 10312
2020
Q3 		$110K Buy
+3,190
New +$202K ﹤0.01% 9868
2019
Q2 		– Sell
-1,190
Closed -$97K – 10855
2019
Q1 		$97K Buy
+1,190
New +$135K ﹤0.01% 8261

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Susquehanna International Group's UBX Position: Q3 2025 in Review

Susquehanna International Group sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 56,720 shares — an estimated $21.6K sold.

Susquehanna International Group first reported a position in UBX in Q4 2018 and held it in 21 quarters. The position peaked at $669K in Q3 2021. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • Susquehanna International Group reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 56,720 Unity Biotechnology shares in Q3 2025, an estimated $21.6K.
  • Susquehanna International Group first reported a position in Unity Biotechnology in Q4 2018 and held it in 21 quarters.
  • Susquehanna International Group's Unity Biotechnology position peaked at $669K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.